|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
CASIRIVIMAB AND IMDEVIMAB |
J06BD07 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005814 |
12-11-2021 |
VALID
|
|
CILTACABTAGENE AUTOLEUCEL |
L01XL05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005095 |
25-05-2022 |
VALID
|
|
CROVALIMAB |
L04AJ07 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006061 |
22-08-2024 |
VALID
|
|
DASIGLUCAGON |
H04AA02 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006214 |
24-07-2024 |
VALID
|
|
DELGOCITINIB |
D11AH11 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006109 |
19-09-2024 |
VALID
|
|
DENGUE VIRUS VACCINES |
J07BX04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005155 |
05-12-2022 |
VALID
|
|
DEUCRAVACITINIB |
L04AF07 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005755 |
24-03-2023 |
VALID
|
|
DOPAMINE |
C01CA04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006044 |
27-05-2024 |
VALID
|
|
EFANESOCTOCOG ALFA |
B02BD02 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005968 |
17-06-2024 |
VALID
|
|
ELAFIBRANOR |
A05AX06 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006231 |
19-09-2024 |
VALID
|
|
ENFORTUMAB VEDOTIN |
L01FX13 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005392 |
13-04-2022 |
VALID
|
|
EPTINEZUMAB |
N02CD05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005287 |
24-01-2022 |
VALID
|
|
ERDAFITINIB |
L01EN01 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006050 |
22-08-2024 |
VALID
|
|
ETRANACOGENE DEZAPARVOVEC |
B06XX00 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004827 |
20-02-2023 |
VALID
|
|
ETRASIMOD |
L04AE05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006007 |
16-02-2024 |
VALID
|
|
EXAGAMGLOGENE AUTOTEMCEL |
B06AX05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005763 |
09-02-2024 |
VALID
|
|
FARICIMAB |
S01LA09 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005642 |
15-09-2022 |
VALID
|
|
FERROUS SULFATE AND FOLIC ACID |
B01AD03 |
PT
|
POM
|
22-10-2024 |
PT/H/0171/001/DC |
26-11-2007 |
VALID
|
|
FEZOLINETANT |
G02CX06 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005851 |
07-12-2023 |
VALID
|
|
FIDANACOGENE ELAPARVOVEC |
B02BD17 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004774 |
24-07-2024 |
VALID
|
|
FINERENONE |
C03DA05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005200 |
16-02-2022 |
VALID
|
|
FLORTAUCIPIR (18F) |
V09AX07 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006064 |
22-08-2024 |
VALID
|
|
FOSDENOPTERIN |
A16AX19 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005378 |
15-09-2022 |
VALID
|
|
FRUQUINTINIB |
L01EK04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005979 |
20-06-2024 |
VALID
|
|
FUTIBATINIB |
L01EN04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005627 |
04-07-2023 |
VALID
|
|
GADOPICLENOL |
V08CA12 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006172 |
07-12-2023 |
VALID
|
|
GALLIUM (68GA) GOZETOTIDE |
V09IX14 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005488 |
09-12-2022 |
VALID
|
|
GANAXOLONE |
N03AX27 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005825 |
26-07-2023 |
VALID
|
|
GLOFITAMAB |
L01FX28 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005751 |
07-07-2023 |
VALID
|
|
INEBILIZUMAB |
L04AG10 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005818 |
25-04-2022 |
VALID
|
|
INFLUENZA VACCINE (LIVE ATTENUATED, NASAL) |
J07BB03 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006514 |
03-06-2024 |
VALID
|
|
INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, PREPARED IN CELL CULTURES) |
J07BB02 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006051 |
19-04-2024 |
VALID
|
|
INSULIN ICODEC |
A10AE07 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005978 |
17-05-2024 |
VALID
|
|
IPTACOPAN |
L04AJ08 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005764 |
17-05-2024 |
VALID
|
|
IVOSIDENIB |
L01XM02 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005936 |
04-05-2023 |
VALID
|
|
LASMIDITAN |
N02CC08 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005332 |
17-08-2022 |
VALID
|
|
LENACAPAVIR |
J05AX31 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005638 |
17-08-2022 |
VALID
|
|
LINZAGOLIX |
H01CC04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005442 |
14-06-2022 |
VALID
|
|
LONAFARNIB |
A16AX20 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005271 |
18-07-2022 |
VALID
|
|
LONAPEGSOMATROPIN |
H01AC09 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005367 |
11-01-2022 |
VALID
|
|
LONCASTUXIMAB TESIRINE |
L01FX22 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005685 |
20-12-2022 |
VALID
|
|
LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN |
V10XX05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005483 |
09-12-2022 |
VALID
|
|
MARALIXIBAT CHLORIDE |
A05AX04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005857 |
09-12-2022 |
VALID
|
|
MELPHALAN FLUFENAMIDE |
L01AA10 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005681 |
17-08-2022 |
VALID
|
|
MIRIKIZUMAB |
L04AC24 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005122 |
26-05-2023 |
VALID
|
|
MITAPIVAT |
B06AX04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005540 |
09-11-2022 |
VALID
|
|
MOMELOTINIB |
L01EJ04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005768 |
25-01-2024 |
VALID
|
|
NIRMATRELVIR AND RITONAVIR |
J05AE30 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005973 |
28-01-2022 |
VALID
|
|
NIRSEVIMAB |
J06BD08 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
NIVOLUMAB AND RELATLIMAB |
L01FY02 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005481 |
15-09-2022 |
VALID
|